Cheryl Walker

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi request reprint Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood
    Cheryl Lyn Walker
    The University of Texas MD Anderson Cancer Center, Department of Molecular Carcinogenesis, Smithville, TX 78957, USA
    Birth Defects Res A Clin Mol Teratol 91:666-71. 2011
  2. ncbi request reprint Arzoxifene as therapy for endometrial cancer
    Thomas W Burke
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 90:S40-6. 2003
  3. pmc Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma
    Adrienne S McCampbell
    Department of Pathology, Science Park Research Division, The University of Texas M D Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX 78957, USA
    Cancer Prev Res (Phila) 3:290-300. 2010

Research Grants

  1. GENETIC DETERMINANTS OF RAT RENAL CARCINOGENESIS
    Cheryl Walker; Fiscal Year: 2007
  2. Molecular Etiology of Leiomyoma Uteri
    Cheryl Walker; Fiscal Year: 2007

Collaborators

  • Thomas W Burke
  • Adrienne S McCampbell
  • Russell R Broaddus
  • Heather A Harris
  • Judy S Crabtree
  • Richard C Winneker

Detail Information

Publications3

  1. ncbi request reprint Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood
    Cheryl Lyn Walker
    The University of Texas MD Anderson Cancer Center, Department of Molecular Carcinogenesis, Smithville, TX 78957, USA
    Birth Defects Res A Clin Mol Teratol 91:666-71. 2011
    ....
  2. ncbi request reprint Arzoxifene as therapy for endometrial cancer
    Thomas W Burke
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 90:S40-6. 2003
    ..Since this is an appealing combination for hormonal therapy of estrogen-related cancers, we initiated testing the potential of arzoxifene in women with treatment-refractory endometrial cancer...
  3. pmc Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma
    Adrienne S McCampbell
    Department of Pathology, Science Park Research Division, The University of Texas M D Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX 78957, USA
    Cancer Prev Res (Phila) 3:290-300. 2010
    ....

Research Grants2

  1. GENETIC DETERMINANTS OF RAT RENAL CARCINOGENESIS
    Cheryl Walker; Fiscal Year: 2007
    ....
  2. Molecular Etiology of Leiomyoma Uteri
    Cheryl Walker; Fiscal Year: 2007
    ..Data generated from these experiments will help elucidate how defective cell cycle regulation and estrogen receptor signaling to contribute to the pathophysiology of leiomyoma uteri. ..